Follow-up in patients with localised primary cutaneous melanoma

Lancet Oncology

Volumn 6, Issue 8, 2005, Pages 608-621

  Francken, Anne Brecht ^a   Bastiaannet, Esther ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; ECHOGRAPHY; EVIDENCE BASED MEDICINE; FOLLOW UP; FREQUENCY ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HEALTH PROGRAM; HUMAN; INCIDENCE; MEDLINE; MELANOMA; PATIENT INFORMATION; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RECURRENCE RISK; REVIEW; SKIN CARCINOMA; THORAX RADIOGRAPHY; WELLBEING;

COSTS AND COST ANALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; QUALITY OF LIFE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 22944491834     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70283-7     Document Type: Review

References (94)

1. Essner R. Lee J.H. Wanek L.A. et al. Contemporary surgical treatment of advanced-stage melanoma Arch. Surg. 2004 139 961-966
2. Tsao H. Atkins M.B. Sober A.J. Management of cutaneous melanoma N. Engl. J. Med. 2004 351 998-1012
3. Balch C.M. Buzaid A.C. Soong S.J. et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J. Clin. Oncol. 2001 19 3635-3648
4. De Vries E. Bray F.I. Coebergh J.W. Parkin D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia Int. J. Cancer 2003 107 119-126
5. Diepgen T.L. Mahler V. The epidemiology of skin cancer Br. J. Dermatol. 2002 146 SUPPL. 61 1-6
6. Rigel D.S. Friedman R.J. Kopf A.W. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century J. Am. Acad. Dermatol. 1996 34 839-847
7. Shumate C.R. Urist M.M. Maddox W.A. Melanoma recurrence surveillance: Patient or physician based? Ann. Surg. 1995 221 566-569
8. Baughan C.A. Hall V.L. Leppard B.J. Perkins P.J. Follow-up in stage I cutaneous malignant melanoma: An audit Clin. Oncol. 1993 5 174-180
9. Brobeil A. Rapaport D. Wells K. et al. Multiple primary melanomas: Implications for screening and follow-up programs for melanoma Ann. Surg. Oncol. 1997 4 19-23
10. Eigentler T.K. Caroli U.M. Radny P. Garbe C. Palliative therapy of disseminated malignant melanoma: A systematic review of 41 randomised clinical trials Lancet Oncol. 2003 4 748-759
11. Weiss M. Loprinzi C.L. Creagan E.T. et al. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 1995 274 1703-1705
12. Hofmann U. Szedlak M. Rittgen W. et al. Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival Br. J. Cancer 2002 87 151-157
13. Garbe C. Paul A. Kohler-Spath H. et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy J. Clin. Oncol. 2003 21 520-529
14. Autier P. Coebergh J.W. Boniol M. et al. Management of melanoma patients: Benefit of intense follow-up schedule is not demonstrated J. Clin. Oncol. 2003 21 3707-3708
15. Saiag P. Recommendations for an effective follow-up strategy in melanoma patients should be tailored to the investigations performed during initial staging J. Clin. Oncol. 2003 21 3706-3707
16. Kalady M.F. White R.R. Johnson J.L. et al. Thin melanomas: Predictive lethal characteristics from a 30-year clinical experience Ann. Surg. 2003 238 528-535
17. Dicker T.J. Kavanagh G.M. Herd R.M. et al. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma Br. J. Dermatol. 1999 140 249-254
18. Johnson R.C. Fenn N.J. Horgan K. Mansel R.E. Follow-up of patients with a thin melanoma Br. J. Surg. 1999 86 619-621
19. Kelly J.W. Blois M.S. Sagebiel R.W. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma J. Am. Acad. Dermatol. 1985 13 756-760
20. Martini L. Brandani P. Chiarugi C. Reali U.M. First recurrence analysis of 840 cutaneous melanomas: A proposal for a follow-up schedule Tumori 1994 80 188-197
21. Moloney D.M. Gordon D.J. Briggs J.C. Rigby H.S. Recurrence of thin melanoma: How effective is follow-up? Br. J. Plast. Surg. 1996 49 409-413
22. Poo-Hwu W.J. Ariyan S. Lamb L. et al. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma Cancer 1999 86 2252-2258
23. Mooney M.M. Kulas M. McKinley B. et al. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma Ann. Surg. Oncol. 1998 5 54-63
24. Fusi S. Ariyan S. Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population Plast. Reconstr. Surg. 1993 91 94-98
25. Basseres N. Grob J.J. Richard M.A. et al. Cost-effectiveness of surveillance of stage I melanoma: A retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 1995 191 199-203
26. Shaw H.M. Beattie C.W. McCarthy W.H. Milton G.W. Late relapse from cutaneous stage I malignant melanoma Arch. Surg. 1985 120 1155-1159
27. Callaway M.P. Briggs J.C. The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma Br. J. Plast. Surg. 1989 42 46-49
28. Crowley N.J. Seigler H.F. Late recurrence of malignant melanoma: Analysis of 168 patients Ann. Surg. 1990 212 173-177
29. Gutman M. Klausner J.M. Inbar M. Rozin R.R. Late recurrence of stage I malignant melanoma J. Surg. Oncol. 1989 42 96-98
30. McEwan L. Smith J.G. Matthews J.P. Late recurrence of localized cutaneous melanoma: Its influence on follow-up policy Plast. Reconstr. Surg. 1990 86 527-534
31. Tahery D.P. Moy R.L. Lack of predictive factors in late recurrence of stage I melanoma Int. J. Dermatol. 1992 31 629-631
32. Leman J.A. Mac Kie R.M. Late (< 10 years) recurrence of melanoma: The Scottish experience Br. J. Dermatol. 2003 148 372-373
33. Schmid-Wendtner M.H. Baumert J. Schmidt M. et al. Late metastases of cutaneous melanoma: An analysis of 31 patients J. Am. Acad. Dermatol. 2000 43 605-609
34. Naruns P.L. Nizze J.A. Cochran A.J. Lee M.B. Morton D.L. Recurrence potential of thin primary melanomas Cancer 1986 57 545-548
35. Brandt S.E. Welvaart K. Hermans J. Is long-term follow-up justified after excision of a thin melanoma (less than or equal to 1.5 mm)? A retrospective analysis of 206 patients J. Surg. Oncol. 1990 43 157-160
36. Kittler H. Weitzdorfer R. Pehamberger H. et al. Compliance with follow-up and prognosis among patients with thin melanomas Eur. J. Cancer 2001 37 1504-1509
37. Schmid-Wendtner M.H. Baumert J. Eberle J. et al. Disease progression in patients with thin cutaneous melanomas (tumour thickness ≤0.75 mm): Clinical and epidemiological data from the Tumour Center Munich 1977-98 Br. J. Dermatol. 2003 149 788-793
38. Regan M.W. Reid C.D. Griffiths R.W. Briggs J.C. Malignant melanoma, evaluation of clinical follow up by questionnaire survey Br. J. Plast. Surg. 1985 38 11-14
39. McCarthy W.H. Shaw H.M. Thompson J.F. Milton G.W. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study Surg. Gynecol. Obstet. 1988 166 497-502
40. Sylaidis P. Gordon D. Rigby H. Kenealy J. Follow-up requirements for thick cutaneous melanoma Br. J. Plast. Surg. 1997 50 349-353
41. Kang S. Barnhill R.L. Mihm M.C. Sober A.J. Multiple primary cutaneous melanomas Cancer 1992 70 1911-1916
42. Slingluff Jr. C.L. Vollmer R.T. Seigler H.F. Multiple primary melanoma: Incidence and risk factors in 283 patients Surgery 1993 113 330-339
43. Ariyan S. Poo W.J. Bolognia J. et al. Multiple primary melanomas: Data and significance Plast. Reconstr. Surg. 1995 96 1384-1389
44. Johnson T.M. Hamilton T. Lowe L. Multiple primary melanomas J. Am. Acad. Dermatol. 1998 39 422-427
45. DiFronzo L.A. Wanek L.A. Morton D.L. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up Cancer 2001 91 1520-1524
46. DiFronzo L.A. Wanek L.A. Elashoff R. Morton D.L. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma Ann. Surg. Oncol. 1999 6 705-711
47. Stam-Posthuma J.J. van Duinen C. Scheffer E. et al. Multiple primary melanomas J. Am. Acad. Dermatol. 2001 44 22-27
48. Nashan D. Kocer B. Schiller M. et al. Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factors Dermatology 2003 206 76-77
49. Goggins W.B. Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors Cancer 2003 97 639-643
50. Burden A.D. Vestey J.P. Sirel J.M. et al. Multiple primary melanoma: Risk factors and prognostic implications BMJ 1994 309 375
51. Kersey P.A. Iscoe N.A. Gapski J.A. et al. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br. J. Surg. 1985 72 614-617
52. Kostrubiak I. Whitley N.O. Aisner J. et al. The use of computed body tomography in malignant melanoma JAMA 1988 259 2896-2897
53. Johnson F.E. Virgo K.S. Johnson D.Y. et al. Effect of initial tumor stage on patient follow-up after potentially curative surgery for cutaneous melanoma Int. J. Oncol. 2001 18 973-978
54. Connell L.E. Verheyden C.N. The efficacy of laboratory studies in the detection of recurrent melanoma Plast. Reconstr. Surg. 2003 111 502-503
55. Barzilai D.A. Cooper K.D. Neuhauser D. et al. Geographic and patient variation in receipt of surveillance procedures after local excision of cutaneous melanoma J. Invest. Dermatol. 2004 122 246-255
56. Brountzos E.N. Panagiotou I.E. Bafaloukos D.I. Kelekis D.A. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma Oncol. Rep. 2003 10 505-510
57. Schmid-Wendtner M.H. Paerschke G. Baumert J. et al. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma Melanoma. Res. 2003 13 183-188
58. Voit C. Mayer T. Kron M. et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients Cancer 2001 91 2409-2416
59. Nazarian L.N. Alexander A.A. Rawool N.M. et al. Malignant melanoma: impact of superficial US on management Radiology 1996 199 273-277
60. Rossi C.R. Seno A. Vecchiato A. et al. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma Eur. J. Cancer 1997 33 200-203
61. Binder M. Kittler H. Steiner A. et al. Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma Eur. J. Cancer 1997 33 1805-1808
62. Prayer L. Winkelbauer H. Gritzmann N. et al. Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma Eur. J. Cancer 1990 26 827-830
63. Blum A. Schlagenhauff B. Stroebel W. et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: Results of a prospective study of 1288 patients Cancer 2000 88 2534-2539
64. Bafounta M.L. Beauchet A. Chagnon S. Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: A meta-analysis Lancet Oncol. 2004 5 673-680
65. Machet L. Perrinaud A. Giraudeau B. Routine ultrasonography in melanoma follow-up? Lancet Oncol. 2005 6 2
66. Provost N. Marghoob A.A. Kopf A.W. et al. Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians J. Am. Acad. Dermatol. 1997 36 711-720
67. Margenthaler J.A Virgo K.S. Johnson D.Y. et al. How surgeon age affects post-treatment surveillance strategies for melanoma patients Int. J. Oncol. 2001 19 175-180
68. Virgo K.S. Chan D. Handler B.S. et al. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma Plast. Reconstr. Surg. 2000 106 590-597
69. Margenthaler J.A. Meier J.D. Virgo K.S. et al. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma Am. J. Surg. 2003 186 194-200
70. Mooney M.M. Mettlin C. Michalek A.M. et al. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: A cost-effectiveness analysis Cancer 1997 80 1052-1064
71. Tsao H. Feldman M. Fullerton J.E. et al. Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival Arch. Dermatol. 2004 140 67-70
72. Longman A.J. Graham K.Y. Living with melanoma: Content analysis of interviews Oncol. Nurs. Forum. 1986 13 58-64
73. Brandberg Y. Mansson-Brahme E. Ringborg U. Sjoden P.O. Psychological reactions in patients with malignant melanoma Eur. J. Cancer 1995 31 157-162
74. Schofield P.E. Beeney L.J. Thompson J.F. et al. Hearing the bad news of a cancer diagnosis: The Australian melanoma patient's perspective Ann. Oncol. 2001 12 365-371
75. Brandberg Y. Bergenmar M. Michelson H. et al. Six-month follow-up of effects of an information programme for patients with malignant melanoma Patient Educ. Couns. 1996 28 201-208
76. Schofield P.E. Butow P.N. Thompson J.F. et al. Psychological responses of patients receiving a diagnosis of cancer Ann. Oncol. 2003 14 48-56
77. Butow P.N. Kazemi J.N. Beeney L.J. et al. When the diagnosis is cancer: Patient communication experiences and preferences Cancer 1996 77 2630-2637
78. Sollner W. Zschocke I. Zingg-Schir M. et al. Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness Psychosomatics 1999 40 239-250
79. Dirksen S.R. Perceived well-being in malignant melanoma survivors Oncol. Nurs Forum. 1989 16 353-358
80. McKenna D.B. Marioni J.C. Lee R.J. et al. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma Br. J. Dermatol. 2004 151 636-644
81. Garbe C. Diagnostic value and prognostic significance of protein S-100beta;, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients Cancer 2003 97 1737-1745
82. The GIVIO Investigators Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial JAMA 1994 271 1587-1592
83. National Research Council Project on Breast Cancer follow-up Rosselli Del Turco M. Palli D. Cariddi A. et al. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial JAMA 1994 271 1593-1597
84. de Bock G.H. Bonnema J. van der Hage J. et al. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: A meta-analysis and systematic review J. Clin. Oncol. 2004 22 4010-4018
85. Fawzy N.W. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients Cancer Nurs. 1995 18 427-438
86. Liberati A The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Interdisciplinary Group for Cancer Care Evaluation Ann Oncol 6 suppl 2 1995 41-46
87. E Grunfeld D Mant P Yudkin Routine follow up of breast cancer in primary care: Randomised trial BMJ 313 1996 665-669
88. Roberts D.L. Anstey A.V. Barlow R.J. et al. UK guidelines for the management of cutaneous melanoma Br. J. Dermatol. 2002 146 7-17
89. Arbeitsgemeinschaft Dermatologischen Onkologie Deutsche Leitlinie: Malignes Melanom http://www.ado-homepage.de/FKHome/FKMM/fkmm.html (accessed July 13, 2005).
90. Scottish Intercollegiate Guidelines Network Cutaneous malignant melanoma, a national guideline http://www.sign.ac.uk/guidelines/ index.html (accessed May 5, 2005).
91. Vereniging voor integrale kankercentra. Conceptrichtlijn melanoom van de huid http://www.oncoline.nl/uploaded/FILES/melanoom/ Conceptrichtlijn%20Melanoom.pdf (accessed May 5, 2005).
92. National Comprehensive Cancer Network Melanoma: Clinical practice guidelines in oncology http://www.nccn.org/ (accesssed May 5, 2005).
93. die Fachskommission 'Hautkrebs'. Guideline zur therapie und nachsorge des kutanen melanoms http://www.melanoma.ch/MMguidel.pdf (accessed May 5, 2005).
94. Australian Cancer Network The management of cutaneous melanoma, 1999 http://www.nhmrc.gov.au/publications/synopses/cp68syn.htm (accessed May 5, 2005).